HIF‑1α protects PC12 cells from OGD/R‑induced cell injury by regulating autophagy flux through the miR‑20a‑5p/KIF5A axis. 2022

Jing-Wei Cao, and Zhan-Bin Tang, and Ji-He Song, and Jia-Lin Yao, and Xiao-Meng Sheng, and Zhi-Qiang Su
Internal Medicine‑Neurology, The First Affiliated Hospital of Harbin Medical University, Harbin, P.R. China.

Hypoxia inducible factor 1α (HIF‑1α) has been reported to play a key role in protecting neurons from ischaemic injury. However, the exact molecular mechanisms remain largely unclear. PC12 cells were exposed to oxygen glucose deprivation/reoxygenation (OGD/R) conditions to mimic ischaemic injury in vitro. The expression of the HIF‑1α mRNA, miR‑20a‑5p, and kinesin family member 5A (KIF5A) mRNA was tested using qRT-PCR. Levels of the HIF‑1α, LC3I/II, P62, LAMP2, cathepsin B (CTSB) and KIF5A proteins were determined using western blotting. The CCK‑8 assay was conducted to assess PC12 cell viability. DQ‑Red‑BSA and LysoSensor Green DND‑189 dyes were employed to measure the proteolytic activity and pH of lysosomes, respectively. The interaction between miR‑20a‑5p and HIF‑1α or KIF5A was verified by performing chromatin immunoprecipitation (ChIP) and/or dual‑luciferase reporter assays. TUNEL staining was adopted to assess PC12 cell death. GFP‑LC3 and RFP‑GFP‑LC3 probes were used to examine the autophagy status and autophagy flux of PC12 cells. A rat middle cerebral artery occlusion‑reperfusion (MCAO/R) model was established to investigate the role of the HIF‑1α/miR‑20a‑5p/KIF5A axis in ischaemic stroke in vivo. OGD/R exposure initiated PC12 cell autophagy and injury. HIF‑1α expression was substantially increased in PC12 cells after OGD/R exposure. Overexpression of HIF‑1α reversed the effects of OGD/R on reducing cell viability, blocking autophagy flux and inducing lysosome dysfunction. These rescue effects of HIF‑1α depended on KIF5A. HIF‑1α negatively regulated miR‑20a‑5p expression by targeting its promoter region, and miR‑20a‑5p directly targeted and negatively regulated the KIF5A mRNA. Overexpression of miR‑20a‑5p abolished the effects of HIF‑1α on rescuing OGD/R‑induced injury in PC12 cells. The effects of the HIF‑1α/miR‑20a‑5p/KIF5A axis were verified in MCAO/R rats. HIF‑1α protects PC12 cells from OGD/R‑induced cell injury by regulating autophagy flux through the miR‑20a‑5p/KIF5A axis.

UI MeSH Term Description Entries
D010100 Oxygen An element with atomic symbol O, atomic number 8, and atomic weight [15.99903; 15.99977]. It is the most abundant element on earth and essential for respiration. Dioxygen,Oxygen-16,Oxygen 16
D002401 Cathepsin B A lysosomal cysteine proteinase with a specificity similar to that of PAPAIN. The enzyme is present in a variety of tissues and is important in many physiological and pathological processes. In pathology, cathepsin B has been found to be involved in DEMYELINATION; EMPHYSEMA; RHEUMATOID ARTHRITIS, and NEOPLASM INVASIVENESS. Cathepsin B-Like Proteinase,Cathepsin B1,Cathepsin B Like Proteinase,Proteinase, Cathepsin B-Like
D002470 Cell Survival The span of viability of a cell characterized by the capacity to perform certain functions such as metabolism, growth, reproduction, some form of responsiveness, and adaptability. Cell Viability,Cell Viabilities,Survival, Cell,Viabilities, Cell,Viability, Cell
D002545 Brain Ischemia Localized reduction of blood flow to brain tissue due to arterial obstruction or systemic hypoperfusion. This frequently occurs in conjunction with brain hypoxia (HYPOXIA, BRAIN). Prolonged ischemia is associated with BRAIN INFARCTION. Cerebral Ischemia,Ischemic Encephalopathy,Encephalopathy, Ischemic,Ischemia, Cerebral,Brain Ischemias,Cerebral Ischemias,Ischemia, Brain,Ischemias, Cerebral,Ischemic Encephalopathies
D005947 Glucose A primary source of energy for living organisms. It is naturally occurring and is found in fruits and other parts of plants in its free state. It is used therapeutically in fluid and nutrient replacement. Dextrose,Anhydrous Dextrose,D-Glucose,Glucose Monohydrate,Glucose, (DL)-Isomer,Glucose, (alpha-D)-Isomer,Glucose, (beta-D)-Isomer,D Glucose,Dextrose, Anhydrous,Monohydrate, Glucose
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001343 Autophagy The segregation and degradation of various cytoplasmic constituents via engulfment by MULTIVESICULAR BODIES; VACUOLES; or AUTOPHAGOSOMES and their digestion by LYSOSOMES. It plays an important role in BIOLOGICAL METAMORPHOSIS and in the removal of bone by OSTEOCLASTS. Defective autophagy is associated with various diseases, including NEURODEGENERATIVE DISEASES and cancer. Autophagocytosis,ER-Phagy,Lipophagy,Nucleophagy,Reticulophagy,Ribophagy,Autophagy, Cellular,Cellular Autophagy,ER Phagy
D012333 RNA, Messenger RNA sequences that serve as templates for protein synthesis. Bacterial mRNAs are generally primary transcripts in that they do not require post-transcriptional processing. Eukaryotic mRNA is synthesized in the nucleus and must be exported to the cytoplasm for translation. Most eukaryotic mRNAs have a sequence of polyadenylic acid at the 3' end, referred to as the poly(A) tail. The function of this tail is not known for certain, but it may play a role in the export of mature mRNA from the nucleus as well as in helping stabilize some mRNA molecules by retarding their degradation in the cytoplasm. Messenger RNA,Messenger RNA, Polyadenylated,Poly(A) Tail,Poly(A)+ RNA,Poly(A)+ mRNA,RNA, Messenger, Polyadenylated,RNA, Polyadenylated,mRNA,mRNA, Non-Polyadenylated,mRNA, Polyadenylated,Non-Polyadenylated mRNA,Poly(A) RNA,Polyadenylated mRNA,Non Polyadenylated mRNA,Polyadenylated Messenger RNA,Polyadenylated RNA,RNA, Polyadenylated Messenger,mRNA, Non Polyadenylated
D015427 Reperfusion Injury Adverse functional, metabolic, or structural changes in tissues that result from the restoration of blood flow to the tissue (REPERFUSION) following ISCHEMIA. Ischemia-Reperfusion Injury,Injury, Ischemia-Reperfusion,Injury, Reperfusion,Reperfusion Damage,Damage, Reperfusion,Injury, Ischemia Reperfusion,Ischemia Reperfusion Injury,Ischemia-Reperfusion Injuries,Reperfusion Damages,Reperfusion Injuries
D016547 Kinesins A family of microtubule-associated mechanical adenosine triphosphatases, that uses the energy of ATP hydrolysis to move organelles along microtubules including mitosis, meiosis, and axonal transport. Kinesin,Kinesin Heavy-Chain Protein,Kinesin Light-Chain Protein,Kinesin Light-Chain Proteins,Kinesin Superfamily,Heavy-Chain Protein, Kinesin,Light-Chain Protein, Kinesin,Light-Chain Proteins, Kinesin,Protein, Kinesin Heavy-Chain,Protein, Kinesin Light-Chain,Proteins, Kinesin Light-Chain,Superfamily, Kinesin

Related Publications

Jing-Wei Cao, and Zhan-Bin Tang, and Ji-He Song, and Jia-Lin Yao, and Xiao-Meng Sheng, and Zhi-Qiang Su
May 2020, Cell cycle (Georgetown, Tex.),
Jing-Wei Cao, and Zhan-Bin Tang, and Ji-He Song, and Jia-Lin Yao, and Xiao-Meng Sheng, and Zhi-Qiang Su
March 2020, Molecular and cellular biochemistry,
Jing-Wei Cao, and Zhan-Bin Tang, and Ji-He Song, and Jia-Lin Yao, and Xiao-Meng Sheng, and Zhi-Qiang Su
July 2019, Brain research,
Jing-Wei Cao, and Zhan-Bin Tang, and Ji-He Song, and Jia-Lin Yao, and Xiao-Meng Sheng, and Zhi-Qiang Su
June 2012, Acta pharmacologica Sinica,
Jing-Wei Cao, and Zhan-Bin Tang, and Ji-He Song, and Jia-Lin Yao, and Xiao-Meng Sheng, and Zhi-Qiang Su
December 2020, Artificial cells, nanomedicine, and biotechnology,
Jing-Wei Cao, and Zhan-Bin Tang, and Ji-He Song, and Jia-Lin Yao, and Xiao-Meng Sheng, and Zhi-Qiang Su
October 2022, Medicine,
Jing-Wei Cao, and Zhan-Bin Tang, and Ji-He Song, and Jia-Lin Yao, and Xiao-Meng Sheng, and Zhi-Qiang Su
April 2020, Bioscience reports,
Jing-Wei Cao, and Zhan-Bin Tang, and Ji-He Song, and Jia-Lin Yao, and Xiao-Meng Sheng, and Zhi-Qiang Su
July 2020, European review for medical and pharmacological sciences,
Jing-Wei Cao, and Zhan-Bin Tang, and Ji-He Song, and Jia-Lin Yao, and Xiao-Meng Sheng, and Zhi-Qiang Su
December 2020, European review for medical and pharmacological sciences,
Jing-Wei Cao, and Zhan-Bin Tang, and Ji-He Song, and Jia-Lin Yao, and Xiao-Meng Sheng, and Zhi-Qiang Su
March 2018, European review for medical and pharmacological sciences,
Copied contents to your clipboard!